secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cogent Biosciences, Inc. (COGT)
CIK:        0001622229
Form:       8-K
Filed at:   2023-06-07T23:59:59+00:00
Accession:  0001193125-23-162557
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cogent Biosciences stockholders approve 6M share increase under 2018 Equity Plan
--------------------------------------------------------------------------------

- All three director nominees elected: Chris Cain, Arlene Morris, Todd Shegog each received >51% of votes cast.
- Proposal to increase shares reserved under 2018 Stock Option Plan by 6,000,000 shares passed with 40,805,846 for, 23,427,202 against.
- Ratification of PricewaterhouseCoopers as independent auditor approved with 65,536,975 votes for, 26,688 against.
- Record date April 10, 2023: 70,946,790 shares entitled to vote.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1622229/000119312523162557/0001193125-23-162557-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1622229/000119312523162557/d500671d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-162557

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer